We are live on
!
Find out more
TC
Trilogy Capital Portfolio holdings
AUM
$2.58B
1-Year Est. Return
22.97%
This Fund
S&P 500
This Quarter
Est. Return
-1.43%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
–
AUM
$1.94B
AUM Growth
-$39.1M
(-2%)
Cap. Flow
+$3.2M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
348
New
24
Increased
157
Reduced
133
Closed
21
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 3.34% |
| 2 | Financials | 1.3% |
| 3 | Healthcare | 1.09% |
| 4 | Industrials | 0.88% |
| 5 | Consumer Discretionary | 0.87% |
Similar funds
GFA
LS
RG
AAS
CWS
DCM
GWP
PCM
Trilogy Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Trilogy Capital held 348 positions worth $1.94B, down 2% from $1.98B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trilogy Capital's Q4 2024 filing shows 24 new, 157 increased, 133 reduced and 21 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 29,805 shares worth $12.7M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $18.7M.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Financials and Healthcare.
- Trilogy Capital's largest Q4 2024 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 29,805 shares worth $12.7M.
- Trilogy Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $12.9M increase.
- Trilogy Capital's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $18.7M.
- Trilogy Capital fully exited State Street Materials Select Sector SPDR ETF in Q4 2024, selling an estimated $5.13M.
- Trilogy Capital's ten largest holdings make up 32% of its $1.94B portfolio in Q4 2024.
- Trilogy Capital opened 24 new positions and closed 21 in Q4 2024.
- Trilogy Capital's portfolio value fell 2% quarter-over-quarter to $1.94B.
Based on Trilogy Capital's 13F filing for Q4 2024, filed 27 Jan 2025.